Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Location
Additional address info
  • c/o Walder Wyss
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2023
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in